Peter is a Director of Vivaldi Biosciences Inc. and a Member of the Supervisory Board of Vivaldi Biosciences AG, and Managing General Partner of NGN Capital LLC. A venture investor with extensive pharma industry experience including strategic planning, corporate development, M&A, marketing, and licensing.